Arthur N. Brodsky, Ph.D.

CRI BlogAuthors
Let's spread the word about Immunotherapy! Click to share this page with your community.
pancreatic cancer clinical accelerator clinical trials

New Hope Against Pancreatic Cancer

January 6, 2021Arthur N. Brodsky, Ph.D.

New publication from the CRI PRINCE trial highlights benefits of an immunotherapy-chemotherapy combination against advanced pancreatic cancer.

Read More

Filter by:
Subscribe

Recent Posts
conferences ASCO

ASCO20 Preview

Arthur N. Brodsky, Ph.D.
May 22, 2020
checkpoint inhibitors bladder cancer clinical trials CAR T cell therapy antibody drug conjugates

Bladder Cancer Immunotherapy Landscape

Arthur N. Brodsky, Ph.D.
May 21, 2020
webinars technology medical imaging pet scans

Immuno-Guided PET Scans

Arthur N. Brodsky, Ph.D.
May 20, 2020
immunology cell biology virology

Role of Viperin in Viral Protection

Arthur N. Brodsky, Ph.D.
May 20, 2020
lymphoma leukemia blood cancers clinical trials COVID-19 mutliple myeloma

COVID-19 and Blood Cancers

Arthur N. Brodsky, Ph.D.
May 08, 2020

*Immunotherapy results may vary from patient to patient.

Contact Us

Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111

800-992-2623212-832-9376Staff Directory

Stay Connected with CRI

Follow us

Recent Blog Posts

National Handwriting Day is Saturday, January 23, 2021. Challenge yourself in 2021 with our '21 Challenge to journal, get creative, correspond with friends, or anything else that brings joy and reflection.

Terence Friedlander, M.D., answers questions about immunotherapy for bladder cancer from the 2020 CRI Virtual Immunotherapy Patient Summit.
Top